About this Journal Submit a Manuscript Table of Contents
ISRN Oncology
Volume 2013 (2013), Article ID 329063, 9 pages
http://dx.doi.org/10.1155/2013/329063
Research Article

PKCε Phosphorylates and Mediates the Cell Membrane Localization of RhoA

1Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA
2Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
3Center for Live-Cell Imaging, Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA
4Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48108, USA
5Van Andel Research Institute, Grand Rapids, MI 49503, USA
6Southwest Michigan Innovation Center, Kalamazoo, MI 49008, USA

Received 9 July 2013; Accepted 18 August 2013

Academic Editors: Y.-y. Liu and Y. Yu

Copyright © 2013 Tizhi Su et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Mischak, J. Goodnight, W. Kolch et al., “Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity,” Journal of Biological Chemistry, vol. 268, no. 9, pp. 6090–6096, 1993. View at Scopus
  2. G. P. Perletti, M. Folini, H.-C. Lin, H. Mischak, F. Piccinini, and A. H. Tashjian Jr., “Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells,” Oncogene, vol. 12, no. 4, pp. 847–854, 1996. View at Scopus
  3. S. D. Tachado, M. W. Mayhew, G. G. Wescott et al., “Regulation of tumor invasion and metastasis in protein kinase C epsilon-transformed NIH3T3 fibroblasts,” Journal of Cellular Biochemistry, vol. 85, no. 4, pp. 785–797, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. P. Jansen, E. G. Verwiebe, N. E. Dreckschmidt, D. L. Wheeler, T. D. Oberley, and A. K. Verma, “Protein kinase C-ε transgenic mice: a unique model for metastatic squamous cell carcinoma,” Cancer Research, vol. 61, no. 3, pp. 808–812, 2001. View at Scopus
  5. D. Wu, T. L. Foreman, C. W. Gregory et al., “Protein kinase Cε has the potential to advance the recurrence of human prostate cancer,” Cancer Research, vol. 62, no. 8, pp. 2423–2429, 2002. View at Scopus
  6. F. Benavides, J. Blando, C. J. Perez et al., “Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions,” Cell Cycle, vol. 10, no. 2, pp. 268–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Pan, L. W. Bao, C. G. Kleer et al., “Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy,” Cancer Research, vol. 65, no. 18, pp. 8366–8371, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Pan, L. W. Bao, T. N. Teknos, and S. D. Merajver, “Targeted disruption of protein kinase Cε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma,” Cancer Research, vol. 66, no. 19, pp. 9379–9384, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Zhao, L. Lu, N. Pokhriyal et al., “Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells,” Cancer Research, vol. 69, no. 2, pp. 483–491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Ma, Y.-P. Liu, C.-Z. Geng, X.-L. Wang, Y.-J. Wang, and X.-H. Zhang, “Over expression of rhoa is associated with progression in invasive breast duct carcinoma,” Breast Journal, vol. 16, no. 1, pp. 105–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Valastyan, F. Reinhardt, N. Benaich et al., “A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis,” Cell, vol. 137, no. 6, pp. 1032–1046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D.-D. Dittert, C. Kielisch, I. Alldinger et al., “Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis,” Human Pathology, vol. 39, no. 7, pp. 1002–1010, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Wang, K. Dou, H. Xiang et al., “Involvement of RhoA in progression of human hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 22, no. 11, pp. 1916–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. X. R. Li, F. Ji, J. Ouyang, W. Wu, L. Y. Qian, and K. Y. Yang, “Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma,” European Journal of Surgical Oncology, vol. 32, no. 10, pp. 1130–1134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Horiuchi, T. Imai, C. Wang et al., “Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma,” Laboratory Investigation, vol. 83, no. 6, pp. 861–870, 2003. View at Scopus
  16. T. Kamai, T. Tsujii, K. Arai et al., “Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer,” Clinical Cancer Research, vol. 9, no. 7, pp. 2632–2641, 2003. View at Scopus
  17. A. Faried, M. Nakajima, M. Sohda, T. Miyazaki, H. Kato, and H. Kuwano, “Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma,” European Journal of Surgical Oncology, vol. 31, no. 4, pp. 410–414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. T. Abraham, M. A. Kuriakose, P. G. Sacks et al., “Motility-related proteins as markers for head and neck squamous cell cancer,” Laryngoscope, vol. 111, no. 7, pp. 1285–1289, 2001. View at Scopus
  19. R. Niggeweg, T. Köcher, M. Gentzel et al., “A general precursor ion-like scanning mode on quadrupole-TOF instruments compatible with chromatographic separation,” Proteomics, vol. 6, no. 1, pp. 41–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Steen, B. Kuster, M. Fernandez, A. Pandey, and M. Mann, “Detection of tyrosine phosphorylated peptides by precursor ion scanning quadrupole TOF mass spectrometry in positive ion mode,” Analytical Chemistry, vol. 73, no. 7, pp. 1440–1448, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Hoppe, K. Christensen, and J. A. Swanson, “Fluorescence resonance energy transfer-based stoichiometry in living cells,” Biophysical Journal, vol. 83, no. 6, pp. 3652–3664, 2002. View at Scopus
  22. A. D. Hoppe and J. A. Swanson, “Cdc42, Rac1, and Rac2 display distinct patterns of activation during phagocytosis,” Molecular Biology of the Cell, vol. 15, no. 8, pp. 3509–3519, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Ubersax and J. E. Ferrell Jr., “Mechanisms of specificity in protein phosphorylation,” Nature Reviews Molecular Cell Biology, vol. 8, no. 7, pp. 530–541, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Biondi and A. R. Nebreda, “Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions,” Biochemical Journal, vol. 372, part 1, pp. 1–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Ben-Levy, S. Hooper, R. Wilson, H. F. Paterson, and C. J. Marshall, “Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2,” Current Biology, vol. 8, no. 19, pp. 1049–1057, 1998. View at Scopus
  26. P. Lang, F. Gesbert, M. Delespine-Carmagnat, R. Stancou, M. Pouchelet, and J. Bertoglio, “Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes,” EMBO Journal, vol. 15, no. 3, pp. 510–519, 1996. View at Scopus
  27. V. Sauzeau, M. Rolli-Derkinderen, C. Marionneau, G. Loirand, and P. Pacaud, “RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation,” Journal of Biological Chemistry, vol. 278, no. 11, pp. 9472–9480, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Rolli-Derkinderen, V. Sauzeau, L. Boyer et al., “Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome- mediated degradation in vascular smooth muscle cells,” Circulation Research, vol. 96, no. 11, pp. 1152–1160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Kallunki, B. Su, I. Tsigelny et al., “JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation,” Genes and Development, vol. 8, no. 24, pp. 2996–3007, 1994. View at Scopus
  30. S. Lee, X. Lin, N. H. Nam, K. Parang, and G. Sun, “Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 14707–14712, 2003. View at Publisher · View at Google Scholar · View at Scopus